CA2859934A1 - Comete de hayley ii - Google Patents

Comete de hayley ii Download PDF

Info

Publication number
CA2859934A1
CA2859934A1 CA2859934A CA2859934A CA2859934A1 CA 2859934 A1 CA2859934 A1 CA 2859934A1 CA 2859934 A CA2859934 A CA 2859934A CA 2859934 A CA2859934 A CA 2859934A CA 2859934 A1 CA2859934 A1 CA 2859934A1
Authority
CA
Canada
Prior art keywords
cultivar
cannabidiolic acid
cannabis
cannabinoid
profile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2859934A
Other languages
English (en)
Inventor
A. Paul Hornby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA2859934A priority Critical patent/CA2859934A1/fr
Publication of CA2859934A1 publication Critical patent/CA2859934A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01HNEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H1/00Processes for modifying genotypes ; Plants characterised by associated natural traits
    • A01H1/04Processes of selection involving genotypic or phenotypic markers; Methods of using phenotypic markers for selection

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
CA2859934A 2014-09-22 2014-09-22 Comete de hayley ii Abandoned CA2859934A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2859934A CA2859934A1 (fr) 2014-09-22 2014-09-22 Comete de hayley ii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2859934A CA2859934A1 (fr) 2014-09-22 2014-09-22 Comete de hayley ii

Publications (1)

Publication Number Publication Date
CA2859934A1 true CA2859934A1 (fr) 2016-03-22

Family

ID=55539873

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2859934A Abandoned CA2859934A1 (fr) 2014-09-22 2014-09-22 Comete de hayley ii

Country Status (1)

Country Link
CA (1) CA2859934A1 (fr)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2541191A (en) * 2015-08-10 2017-02-15 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
US10092525B2 (en) 2014-10-14 2018-10-09 Gw Pharma Limited Use of cannabinoids in the treatment of epilepsy
CN108743571A (zh) * 2018-08-07 2018-11-06 云南汉木森生物科技有限责任公司 预防、治疗癫痫的药物组合物及其制备方法
CN110632224A (zh) * 2019-09-16 2019-12-31 福建省中科生物股份有限公司 一种麻类植物指纹图谱的建立方法
US10583096B2 (en) 2016-03-31 2020-03-10 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US10603288B2 (en) 2014-06-17 2020-03-31 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US10709671B2 (en) 2015-06-17 2020-07-14 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US10729665B2 (en) 2011-09-29 2020-08-04 Gw Pharma Limited Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
US10765643B2 (en) 2014-10-14 2020-09-08 GW Research Limited Use of cannabidiol in the treatment of epilepsy
US10918608B2 (en) 2014-10-14 2021-02-16 GW Research Limited Use of cannabidiol in the treatment of epilepsy
US11065227B2 (en) 2016-08-25 2021-07-20 GW Research Limited Use of cannabinoids in the treatment of multiple myeloma
US11160757B1 (en) 2020-10-12 2021-11-02 GW Research Limited pH dependent release coated microparticle cannabinoid formulations
US11160795B2 (en) 2020-02-27 2021-11-02 GW Research Limited Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
US11229612B2 (en) 2016-07-01 2022-01-25 GW Research Limited Parenteral formulations
US11291631B2 (en) 2016-07-01 2022-04-05 GW Research Limited Oral cannabinoid formulations
US11426362B2 (en) 2017-02-17 2022-08-30 GW Research Limited Oral cannabinoid formulations
US11679087B2 (en) 2016-12-16 2023-06-20 GW Research Limited Use of cannabinoids in the treatment of Angelman syndrome
US11806319B2 (en) 2018-01-03 2023-11-07 GW Research Limited Pharmaceutical composition comprising a cannabinoid
US12121499B2 (en) 2011-09-29 2024-10-22 Gw Pharma Ltd. Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)

Cited By (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10729665B2 (en) 2011-09-29 2020-08-04 Gw Pharma Limited Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
US12121499B2 (en) 2011-09-29 2024-10-22 Gw Pharma Ltd. Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
US11318109B2 (en) 2011-09-29 2022-05-03 Gw Pharma Limited Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
US11963937B2 (en) 2014-06-17 2024-04-23 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US11766411B2 (en) 2014-06-17 2023-09-26 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US11701330B2 (en) 2014-06-17 2023-07-18 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US11311498B2 (en) 2014-06-17 2022-04-26 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US10603288B2 (en) 2014-06-17 2020-03-31 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US11154516B2 (en) 2014-06-17 2021-10-26 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US11154517B2 (en) 2014-10-14 2021-10-26 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US10137095B2 (en) 2014-10-14 2018-11-27 Gw Pharma Limited Use of cannabinoids in the treatment of epilepsy
US10709674B2 (en) 2014-10-14 2020-07-14 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US10765643B2 (en) 2014-10-14 2020-09-08 GW Research Limited Use of cannabidiol in the treatment of epilepsy
US10092525B2 (en) 2014-10-14 2018-10-09 Gw Pharma Limited Use of cannabinoids in the treatment of epilepsy
US10849860B2 (en) 2014-10-14 2020-12-01 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US11446258B2 (en) 2014-10-14 2022-09-20 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US10918608B2 (en) 2014-10-14 2021-02-16 GW Research Limited Use of cannabidiol in the treatment of epilepsy
US10966939B2 (en) 2014-10-14 2021-04-06 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US11633369B2 (en) 2014-10-14 2023-04-25 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US11065209B2 (en) 2014-10-14 2021-07-20 GW Research Limited Use of cannabidiol in the treatment of epilepsy
US11096905B2 (en) 2014-10-14 2021-08-24 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US11400055B2 (en) 2014-10-14 2022-08-02 GW Research Limited Use of cannabidiol in the treatment of epilepsy
US10111840B2 (en) 2014-10-14 2018-10-30 Gw Pharma Limited Use of cannabinoids in the treatment of epilepsy
US10709673B2 (en) 2014-10-14 2020-07-14 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US12064399B2 (en) 2015-06-17 2024-08-20 Jazz Pharmaceuticals Research Uk Limited Use of cannabinoids in the treatment of epilepsy
US10709671B2 (en) 2015-06-17 2020-07-14 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US11357741B2 (en) 2015-06-17 2022-06-14 GW Research Limited Use of cannabinoids in the treatment of epilepsy
GB2541191A (en) * 2015-08-10 2017-02-15 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
US11147783B2 (en) 2015-08-10 2021-10-19 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US11684598B2 (en) 2015-08-10 2023-06-27 GW Research Limited Use of cannabinoids in the treatment of epilepsy
EP3769755A1 (fr) 2015-08-10 2021-01-27 GW Research Limited Utilisation de l acide cannabidiolique dans le traitement de l'épilepsie
US10583096B2 (en) 2016-03-31 2020-03-10 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US11291631B2 (en) 2016-07-01 2022-04-05 GW Research Limited Oral cannabinoid formulations
US12064398B2 (en) 2016-07-01 2024-08-20 Jazz Pharmaceuticals Research Uk Limited Parenteral formulations
US11229612B2 (en) 2016-07-01 2022-01-25 GW Research Limited Parenteral formulations
US11065227B2 (en) 2016-08-25 2021-07-20 GW Research Limited Use of cannabinoids in the treatment of multiple myeloma
US11679087B2 (en) 2016-12-16 2023-06-20 GW Research Limited Use of cannabinoids in the treatment of Angelman syndrome
US11426362B2 (en) 2017-02-17 2022-08-30 GW Research Limited Oral cannabinoid formulations
US11806319B2 (en) 2018-01-03 2023-11-07 GW Research Limited Pharmaceutical composition comprising a cannabinoid
CN108743571B (zh) * 2018-08-07 2020-10-02 云南汉木森生物科技有限责任公司 预防、治疗癫痫的药物组合物及其制备方法
CN108743571A (zh) * 2018-08-07 2018-11-06 云南汉木森生物科技有限责任公司 预防、治疗癫痫的药物组合物及其制备方法
CN110632224A (zh) * 2019-09-16 2019-12-31 福建省中科生物股份有限公司 一种麻类植物指纹图谱的建立方法
CN110632224B (zh) * 2019-09-16 2022-02-15 福建省中科生物股份有限公司 一种麻类植物指纹图谱的建立方法
US11160795B2 (en) 2020-02-27 2021-11-02 GW Research Limited Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
US12102619B2 (en) 2020-02-27 2024-10-01 Jazz Pharmaceuticals Research Uk Limited Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
US11406623B2 (en) 2020-02-27 2022-08-09 GW Research Limited Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
US11160757B1 (en) 2020-10-12 2021-11-02 GW Research Limited pH dependent release coated microparticle cannabinoid formulations

Similar Documents

Publication Publication Date Title
CA2859934A1 (fr) Comete de hayley ii
CA2737447A1 (fr) "hayley's comet"
Mikulic-Petkovsek et al. Investigation of anthocyanin profile of four elderberry species and interspecific hybrids
Ahn et al. Dimethyl sulfoxide inhibits NLRP3 inflammasome activation
Kipper et al. Meta-analysis of the effects of endoparasites on pig performance
Priyadarshini et al. Astaxanthin inhibits cytokines production and inflammatory gene expression by suppressing IκB kinase-dependent nuclear factor κB activation in pre and postpartum Murrah buffaloes during different seasons
NZ715957A (en) Compartmentalized method of nucleic acid delivery and compositions and uses thereof
Yang et al. Resveratrol sustains intestinal barrier integrity, improves antioxidant capacity, and alleviates inflammation in the jejunum of ducks exposed to acute heat stress
Gao et al. Supplementation of xanthophylls decreased proinflammatory and increased anti-inflammatory cytokines in hens and chicks
ME00830B (fr) Utilisation de chitosane pour augmenter le taux de croissance des ongles
Liu et al. Pod mildew on soybeans can mitigate the damage to the seed arising from field mold at harvest time
Mirabbasi et al. Prevention of shoot tip necrosis, hyperhydricity and callus production associated with in vitro shoot culture of Ulmus glabra
JP5070040B2 (ja) 血管不全改善剤
CA2859927A1 (fr) Empreinte genetique gcg et profil clhp
Panjeshahin et al. Genetic and morphological diversity of wild mint
Dąbrowski et al. Cannabinoids from Cannabis sp.: Mechanism of their activity and potential health benefits in human body
RU2020119597A (ru) Композиция для лечения пациента с респираторным заболеванием, обусловленным хроническим воспалением, способ получения и применение указанной композиции
AU2020323302A1 (en) Improved methods for the production of plants
BR112022011326A2 (pt) Conjugado entre um biopolímero e um agente antimicrobiano fotoativável para combate de doenças fúngicas de interesse agrícola e métodos para produção dos ditos conjugados
TWI702959B (zh) 開發黃花蟛蜞菊的標準化與功效最佳化的草藥抽出物以及其用於治療疾病的用途
Mail et al. Anti-hyphal properties of potential bioactive compounds for oral rinse in suppression of Candida growth
US20230255159A1 (en) Varin profiles
Gocsik et al. Impact of different production systems on health care costs in the Dutch broiler farms
Yazdanpanah et al. Determination of chemical composition and anti-fungal activities of aromatic water of Zataria multiflora Boiss.
TW202330003A (zh) 用於預防或治療癌症的組成物、其製法及用途

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20170922

FZDE Discontinued

Effective date: 20170922